Beta
412956

Molecular and Biochemical Study for the Association of CYP1A1 Gene Polymorphisms with Increase the Risk of Breast Cancer

Article

Last updated: 25 Feb 2025

Subjects

-

Tags

-

Abstract

As a prevalence disease, breast cancer studies focus on the variations occurring with genes involved on the carcinogenesis. The CYP1A1 one of the most important cytochromes in (CYP1) family, which is exists at most in tissues (extrahepatic) and contributing in the metabolism process of a wide kinds of the xenobiotics, as well as many of endogenous substrates.  Cytochrome CYP1A1 catalyzes several of reactions, but there is a unique reaction, hydroxylation of an aromatic ring at an unoccupied position producing of high reactive species that can cause carcinogenic mutations, considered to be the hallmark of CYP1A1 to initiate the carcinogenesis. so that one of the most interesting genes was CYP1A1.The current study was included 100 patients affected with breast cancer and others 100 healthy women as control group, where aimed to evaluating the role of (CYP 1A1) gene polymorphisms and the association with the risk of breast cancer among Egyptian women and its relation with biochemical investigations, hematological parameters, and tumor marker.

DOI

10.21608/mjcc.2020.412956

Keywords

CYP1A1 rs4646903: c.*1189 T > C gene, breast cancer

Volume

50

Article Issue

4

Related Issue

53938

Issue Date

2020-12-01

Receive Date

2025-02-19

Publish Date

2020-12-01

Page Start

17

Page End

26

Print ISSN

1687-5060

Online ISSN

2974-4938

Link

https://micc.journals.ekb.eg/article_412956.html

Detail API

http://journals.ekb.eg?_action=service&article_code=412956

Order

412,956

Type

Original Article

Type Code

3,440

Publication Type

Journal

Publication Title

Mansoura Journal of Chemistry

Publication Link

https://micc.journals.ekb.eg/

MainTitle

Molecular and Biochemical Study for the Association of CYP1A1 Gene Polymorphisms with Increase the Risk of Breast Cancer

Details

Type

Article

Created At

25 Feb 2025